Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 44,033,000 | 47,267,000 | 48,047,000 | 45,987,000 | 27,428,000 |
| Cost of Goods | 16,954,000 | 16,446,000 | 16,871,000 | 18,396,000 | 9,019,000 |
| Gross Profit | 27,079,000 | 30,821,000 | 31,176,000 | 27,591,000 | 18,409,000 |
| Operating Expenses | 19,414,000 | 20,944,000 | 22,200,000 | 24,236,000 | 14,388,000 |
| Operating Income | 7,665,000 | 9,877,000 | 8,976,000 | 3,355,000 | 4,021,000 |
| Other Income | -2,120,000 | -1,138,000 | -1,642,000 | -1,702,000 | 11,269,000 |
| Pre-tax Income | 5,545,000 | 8,739,000 | 7,334,000 | 1,653,000 | 15,290,000 |
| Income Tax | 1,028,000 | 2,440,000 | 942,000 | 671,000 | 2,268,000 |
| Net Income Continuous | 4,517,000 | 6,299,000 | 6,392,000 | 982,000 | 13,022,000 |
| Minority Interests | 113,000 | 131,000 | 120,000 | 121,000 | 123,000 |
| Net Income | $4,404,000 | $6,168,000 | $6,272,000 | $861,000 | $12,899,000 |
| EPS Basic Total Ops | 1.49 | 2.03 | 2.04 | 0.28 | 5.67 |
| EPS Basic Continuous Ops | 1.52 | 2.07 | 2.08 | 0.32 | 5.74 |
| EPS Diluted Total Ops | 1.47 | 2.00 | 2.02 | 0.28 | 5.65 |
| EPS Diluted Continuous Ops | 1.51 | 2.05 | 2.07 | 0.31 | 5.73 |
| EBITDA(a) | $14,653,000 | $16,855,000 | $16,403,000 | $10,736,000 | $6,597,000 |